Background: This article was aimed to test the use of validation rules for blood smear review after automated hematological testing using Mindray CAL-8000 (two hematological analyzers and one autoslider).
| INTRODUCTION
The complete blood cell count (CBC), also including the leukocyte differential (DIFF-profile), is one of the most requested laboratory test in routine clinical practice. Due to the introduction of a new generation of automated hemocytometers, a kaleidoscope of quantitative and qualitative information has become available along with the traditional parameter of the CBC, mostly in form of flags or scattergrams. [1] [2] [3] Morphological flags play a crucial role not only for identifying cellular abnormalities, but also for reliably detecting preanalytical or analytical pitfalls such as platelet clumps or erythrocytes agglutination. [4] [5] [6] The generation of morphological flags is mainly aimed at improving the dissection between normal and pathological blood samples, thus enhancing the appropriateness of optical microscopy (OM) examination. Nonetheless, several lines of evidence now attest that the diagnostic performance of different morphological flags, in terms of sensitivity and specificity, varies widely among the various hematological analyzers which are currently available in the market. [4] [5] [6] The presence of real or spurious abnormalities of many laboratory investigations can be further investigated by adding new tests to existing requests either automatically, on the basis of predefined algorithms (i.e., reflex testing), or manually by laboratory professionals (i.e., flags. The appropriate setting of criteria and rules for activating this type of reflective/reflex testing was found to be effective to greatly limit the number of specimens really necessitating OM evaluation. [7] [8] [9] [10] Due to the constant increasing of automation and shortage of skilled personnel, the OM review of blood smears has become a challenging issue for the organization of modern clinical laboratories, which are forced to analyze large volumes of samples in short time, with high accuracy and minimizing the risk of producing false negative results. [10] [11] [12] [13] The appropriate use of automated hematology hence requires the accurate knowledge and evaluation of both sensitivity and specificity of the technology, as well as of the algorithms and rules for blood smear review. The need to establish a uniform behavior between laboratories has led to the definition of a panel of 
| MATERIALS AND METHODS

| Blood samples
This study was based on 1013 peripheral blood samples (PB) collected in K 3 EDTA tubes (Becton Dickinson, Franklin Lakes, NJ, USA) and referred to the clinical laboratory of Papa Giovanni XXIII Hospital in Bergamo for routine hematological testing. The routine samples used in this study were identified using a sequential criterion until attaining a number of 1000 specimens, which has been arbitrarily fixed as our minimum target. More specifically, the first 20 samples received in the laboratory between 9.00 and 11.00 am were selected on the first day, the first 20 samples received in the laboratory between 11.00 and 12.00 am were selected on the second consecutive day, whereas the first 20 samples received in the laboratory between 1.00 and 2.00 pm were selected on the third consecutive day. On the fourth day, the protocol was replicated for three other consecutive days. The protocol was repeated (for overall 18 days) until obtaining the minimum target of samples that has been originally planned (i.e., >1000).
A workflow analysis (i.e., the time necessary for completing testing, the percentage of results directly released to the clinics, the percentage of reflex testing activation and blood smear review) was also carried out during this investigation for three consecutive days, by analyzing a total number of 2595 samples, corresponding to the routine activity of the local laboratory between 8 and 12 am, and entailing 853 samples on the first day, 891 on samples on the second day, and 851 samples on the third day, respectively.
The PB analysis was carried out using CAL-8000 (Mindray, Shenzhen-China), the largest core model produced by Mindray, and composed by three analytical modules integrated within a single system (i.e., two BC-6800 analyzers and one automatic Autoslider instrumentation SC-120). The analysis of all samples was performed according to manufacturer's instructions, and the quality of data was evaluated by internal quality control assessment using a proprietary material on three different levels. 14 A peripheral blood smear was also automatically prepared for all samples, using Autoslider SC-120 and
May-Grunwald-Giemsa staining (Carlo Erba, Italy).
| Morphological analysis of blood smears
All samples included in this study underwent morphological analy- 
| Local validation of rules for blood smear review
Two panels of rules were used and validated for selecting samples needing OM analysis (i.e., classified as positive) after automated hematological testing. The former panel, known as "41-ICGH rules" is that proposed by the ICGH, 10 whereas the latter has been locally defined after critical review of the literature and the analytical performance of CAL-8000 ( 
| Workflow analysis
The CAL-8000 system is equipped with the middleware LabExpert for workflow management, through which a number of rules can be defined, including (a) automatic release of results; (b) stop releasing data needing operator's evaluation; (c) stop releasing data and implementation of automated reflex testing (e.g., nucleated red blood cells counting using a separate channel, reticulocytes enumeration, platelets counting using optical technique); (d) stop releasing data and automatic preparation of blood smears. The rules were also tested using delta check for comparing data of the same patient at 7 days for the following parameters: platelets (delta check, ±30%), hemoglobin (delta check, ±20%), leukocytes (delta check, ±50%), and automated reflex test for NRBC count with red cell distribution width (RDW) >22, and/ or morphology flag: "NRBC present".
| Statistical analysis
The statistical analysis was carried out using Analyse-it (software version 3.90.1; Analyse-it software Ltd; Leeds, UK). The statistical significance was set at P<.05. The study was performed according to the Declaration of Helsinki, under the terms of all relevant local legislation and with approval of the local ethical Committee. The study was also based on routine samples, which were used for the study protocol in an anonymous form, only once routine analyses were completed.
| RESULTS
Out of the 1013 samples included in the study, 39% were from women and 61% from men, respectively. The mean age of the pa- 7.1%), and mostly attributable to the cut-offs proposed by the ICGH (45% FP for platelet count and 38% FP for leukocyte count) ( Table 4) .
As regards the locally defined validation rules (Table 1) kappa, 0.70; 95% CI, 0.65-0.74), whereas the sensitivity was 0.97 and the specificity was 0.74, respectively. Overall, 14 samples (i.e., 1.4%)
were classified as FN according to the locally defined validation rules (i.e., samples positive for OM analysis but not selected for blood smear analysis after automated hematological testing according to validation rules), eight for the presence of myelocytes and metamyelocytes, two for the presence of nucleated red blood cells, one displayed morphological platelet abnormalities and three were found to have significant neutrophil dysplasia (Table 3 ). The number of FP samples (sample negative for OM analysis but still selected for blood smear analysis after automated hematological testing according to validation rules) was instead higher (142;14%), and mostly attributable to the cut-off used for flagging the lymphocyte (i.e., 44% FP) and leukocyte (i.e., 27% FP) counts (Table 4) .
Due to the greater sensitivity of the locally developed validation rules compared to the "41-ICGH rules" proposed by the ICGH (0.97 vs 0.95), we evaluated the practical use of the former approach on CAL-8000 for three consecutive days, using delta check criteria (Table 5) .
Interestingly, the throughput of the system composed by two he- full-time equivalent (FTE) of technical staff and 0.7 FTE of personnel for clinical validation of data and blood smear review. The percentage of FP data was nearly double using locally defined criteria compared to the "41-ICGH rules" (14% vs 7%), but this value was still comprised within the 18.6% limit set by the consensus group.
| DISCUSSION
The comparison of our data with those previously published shows that the percentage of FP and FN samples is comparable or even better than what has been earlier obtained, wherein these percentages typically ranged between 11.3% and 17.3% for FP samples and between 2.2% and 14.3% for FN samples, respectively. 9, 11, 18, 19 The sensitivity and specificity data are also rather similar to those previously reported, which were comprised between 0.41 and 0.86, and 0.77 and 0.94, respectively. 9, 11, 19 Interestingly, the implementation of the panel of locally defined criteria in routine activity of the CAL-8000 system was associated with a percentage of blood samples needing OM analysis comprised between 14% and 17%. These modest variations are obviously attributable to the different type of samples and patients' case mix across the 3 days of evaluation.
In conclusion, the results of our study show that customization of validation rules is a necessary step for enhancing the quality of hematological testing and optimizing the workflow. Our preliminary model was found to be suitable for routine use on the Mindray CAL-8000
technology, but necessitates confirm in other laboratories with differing case mix and instrumentation.
